# Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis

> **NCT04450030** · — · UNKNOWN · sponsor: **University Hospital Muenster** · enrollment: 204 (estimated)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Methyl Prednisolonate
- **PROCEDURE:** Immunoadsorption

## Key facts

- **NCT ID:** NCT04450030
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-09-05
- **Final completion:** 2020-12-31
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2020-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04450030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04450030, "Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04450030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*